Patients Need Effective Cancer Treatment 

Current immunotherapies only help niche patient populations. 
Qrono sees hope from an immunoengineering approach.
Learn More
Advancing cancer therapy at the interface of engineering and immunology

 

Eloquent™ Immunotherapy rewrites tumor-immune cell communication

 

Copyright © 2020 Qrono Inc.  

 All Rights Reserved.